Literature DB >> 25889031

Medicinal plant knowledge in Caribbean Basin: a comparative study of Afrocaribbean, Amerindian and Mestizo communities.

Wendy Torres-Avilez1, Martha Méndez-González2, Rafael Durán-García3, Isabelle Boulogne4, Lionel Germosén-Robineau5.   

Abstract

BACKGROUND: The Caribbean Basin has complex biogeographical and cultural histories that have shaped its highly diverse botanical and cultural landscapes. As a result, the current ethnic composition of the Basin is a heterogeneous mixture including Amerindian, Afrocaribbean and a wide range of Mestizo populations. A comparison was done of the medicinal plant repertoires used by these groups to identify the proportion of native species they include and any differences between the groups.
METHODS: The TRAMIL program has involved application of ethnopharmacological surveys to gather data on the medicinal plants used for primary care in 55 locations the Caribbean Basin. Three Afrocaribbean, three Amerindian and three Mestizo communities were selected taking in account the Ethnic prevalence. Differences in native and exotic plant used by groups and between groups were done using contingency tables. Identification of differences in the numbers of native and exotic plants used within each group was done with a one sample Z -test for proportions. Similarity in medicinal species use was estimated using the Sørensen Similarity Index. Species use value (UV) was estimated and a principal components analysis (PCA) run to determine differences between groups.
RESULTS: The 1,753 plant records generated from the surveys of the nine communities included in the analysis covered 389 species from 300 genera and 98 families. The studied groups used different numbers of native and exotic species: Afrocaribbean (99 natives, 49 exotics); Amerindian (201 natives, 46 exotics); and Mestizo (63 natives, 44 exotics). The proportion of natives to exotics was significantly different in between the Afrocaribbean and Amerindian communities, and between the Amerindian and Mestizo communities, but not between the Afrocaribbean and Mestizo communities. In the PCA, the groups were disparate in terms of the use value they assigned to the medicinal species; these were determined according to species with high use value and those used exclusively be a particular group
CONCLUSIONS: Although migration, cultural intermixing and a consequent hybridization of medicinal plant knowledge have occurred in the Caribbean Basin, the results highlight differences between the three studied groups in terms of the medicinal plant repertoire they employ for primary health care.

Entities:  

Mesh:

Year:  2015        PMID: 25889031      PMCID: PMC4347915          DOI: 10.1186/s13002-015-0008-4

Source DB:  PubMed          Journal:  J Ethnobiol Ethnomed        ISSN: 1746-4269            Impact factor:   2.733


Background

Floral diversity is distinctive in the Caribbean Basin. The region encompasses portions of North, Central and South America, as well as the Caribbean islands, some of which exhibit different degrees of isolation [1]. Regional geological and biogeographic events, in association with its geographical complexity, have promoted diversity on many fronts. In tandem with the Basin’s social history during the last five hundred years, these biogeographic events have contributed to shaping its biological diversity, with a unique mix of native and exotic species [2,3]. When European contact began in the Basin in the late 15th Century, a process was begun of severe transformations in ecosystems, natural resources, human groups and cultural components [4]. Significant changes in biodiversity were initiated; for example, deforestation to make way for crops such as sugar cane, banana, tobacco and coffee, active exploitation of native plants and animals and introduction of many exotic species [5-8]. The indigenous peoples of the Caribbean islands were almost totally decimated and replaced by slaves, largely from Africa and Asia, who were used as labor in the developing cultivation and extraction systems. In the islands, slaves mainly mixed with Europeans [4,9,10], but along the Basin’s continental margins both slaves and Europeans mixed with surviving indigenous populations [9,10]. As a result, the current ethnic composition of the Basin is a heterogeneous mixture including Amerindian, Afrocaribbean and a wide range of Mestizo populations [10-13]. The cultural change initiated with European contact influenced local knowledge of pharmacopeias since the surviving indigenous populations were forced to adopt new cultural practices, and enter into new economic and political processes [14,15]. Human migration and the cultural and racial intermixture that it assumes [16-18], clearly contributed to an exchange of medicinal plant species, allowing the introduction of new species and the development of new uses for existing species. Native pharmacopeias consequently diversified. Since 1982, the TRAMIL program (Program of Applied Research to Popular Medicine in the Caribbean) has been documenting medicinal plants and their uses throughout the countries of the Caribbean Basin [19] and taking into account that medicinal resource selection and use are influenced by culture (indigenous and/or introduced), regional resource availability and time of residence [20-23], the present study objective was to determine if indigenous populations, given their experience exploiting native floral diversity, use a larger number of native plants than exotics, and if differences exist between Caribbean Basin Afrocaribbean, Amerindian and Mestizo communities in terms of their knowledge and use of medicinal plant resources.

Methods

Study area

The Caribbean Basin consists of the eastern Yucatan Peninsula, Central America, northern South America, the Bahamas and the Greater and Lesser Antilles [1]. Its geology is complex, with the North American, South American and Caribbean tectonic plates all crossing the region. Floral diversity is extremely high, with high rates of endemism. Hotspots with particularly high rates of endemic species include the islands of Cuba (53%) and Hispaniola (30%) [1,24]. Myers and his collaborators [24] estimate floral species richness in South Florida and the Caribbean islands to be 12,000 species, including endemic species representing 2.3% of all vascular plants on the planet (Table 1).
Table 1

Numbers of vascular plant species, estimated number of medicinal plants and percentages of endemism for all the surveyed communities

Study area Number of vascular plant species Number of medicinal plants % of endemism References
Belize44236419[25,26]
Jamaica274611631[1,27]
Haiti468516130[1,28]
Mexico30 000500052[29,25]
Nicaragua5796-700022919[25,30]
Panama8500-900026519[25,31]
Cuba601510153[1,32]
Puerto Rico212817210[1,33]
Dominican Republic468520030[1,34]
Numbers of vascular plant species, estimated number of medicinal plants and percentages of endemism for all the surveyed communities

Data collection

The data analyzed here was collected as part of TRAMIL over a thirty-two year period (1982–2014) in 55 locations in 29 countries and territories in the Basin. Data were collected via ethnopharmacological surveys based on the health problems most affecting each surveyed community. The list of health problems was elaborated by a local multidisciplinary group (nurse, social worker, mothers, traditional healer, etc.) in order to adapt it to the realities of the country. A random selection was made of 10% of the households in each community, and interviews held with the person responsible for household member health, usually the mother. Information was gathered on the plant species used in treatment of each disorder and preparation methods. The medicinal plants recorded in the interviews were identified by specialists from each country’s national plant collection, and specimens deposited in each collection. Specimens of each collected plant were also deposited in the Santo Domingo Botanical Garden Herbarium in the Dominican Republic [35]. From the total sample of communities surveyed by TRAMIL, three Afrocaribbean, three Amerindian and three Mestizo communities were selected taking in account the Ethnic prevalence; besides, the communities selected are recognized themselves as Afrocaribbean, Amerindian and Mestizo (Table 2). Afrocaribbean communities were those in which most inhabitants were descendants of the African diaspora resulting from the slave trade between the 16th and 19th centuries [36]. One group typical of these communities is the Garifuna, found along the coasts of Belize, Guatemala, Honduras and Nicaragua [12,30]. Amerindian communities were those in which inhabitants had preserved the language, social and cultural practices of their places of origin, despite sociocultural mixture [37]. Mestizo communities were those in which inhabitants had neither substantial Afrocaribbean nor indigenous influences, and manifested the traits of other migrant cultures, with a markedly Western lifestyle [11,38].
Table 2

Selected communities in each human group in the Caribbean Basin

Surveyed communities Number of informants Ethnic prevalence Surveyed communities Number of informants Ethnic prevalence Surveyed communities Number of informants Ethnic prevalence
Belize (Caribbean Coast)200 Afro Caribbeans: prevalence of the African diaspora’s descendantsMéxico (Felipe Carrillo Puerto)252 Amerindians: prevalence of pre-Columbian inhabitants’ descendantsCuba (Trinidad)127 Mestizos: prevalence of mixed race persons (descendants with a mix of European, African and Amerindian characteristics)
Jamaica270Nicaragua (Bosawás)139Puerto Rico (Eastern Region)351
Haití (La Chapelle)200Panamá (Bugle)197República Dominicana (Zambrana- jacobo-claro)95
Selected communities in each human group in the Caribbean Basin

Database

Data collected from the surveys was used to build a database (Microsoft Excel 2010©) divided into three sections: taxonomy; geography; and ethnobotany. Accuracy of data in the taxonomic section was confirmed by checking the main TRAMIL specimen collection in the JBSD, the herbarium at the Yucatan Center for Scientific Research (CICY), and the TROPICOS database of the Missouri Botanical Garden. Recorded health disorders were classified into fourteen categories according to the World Health Organization (WHO) international classification of diseases [39]. Species distribution was divided into native and exotic plants. Native species were those distributed naturally throughout the Caribbean Basin, while exotics were those for which natural distribution does not include the Basin. Distribution was determined by consulting fourteen national and regional floras, including those for Guatemala, the Bahamas archipelago, Cuba, Hispaniola, Mesoamerica and Nicaragua. In addition, the GRIN (US Department of Agriculture) [40] and TROPICOS (Missouri Botanical Garden) databases were consulted.

Data analysis

Comparison among ethnic groups was done by first counting the number of plant families and species with medicinal uses in each group and then counting the number of species in each use category. Differences in native and exotic plant used by groups were done using a 2×3 contingency table; 2×2 contingency tables were done to detect differences between groups. Identification of differences in the numbers of native and exotic plants used within each group was done with a one sample z-test for proportions. Intergroup similarities in use of a plant resource were estimated with the Sørensen Similarity Index [41]: SSI = (2c/A + B) × 100; where c = is the sum of the number of species held in common between groups, A = is the number of species for group 1 and B = is the number of species for group 2. Use value (UV) was calculated with the formula UV = ∑U /n proposed by Phillips and Gentry [42] and modified by Rossato and his collaborators [43] to determine the species more used therapeutically in each group. A non-parametric Kruskal-Wallis test was applied to calculate the mean of a species’ use value between groups. Statistical analyses were run with the BioEstat 5.3© program [44]. A principal components analysis (PCA) was run to determine the degree of group clustering based on the use value of medicinal species used by each group. This analysis was done with the MVSP 3.1© program [45].

Results and discussion

Plant species used for the Afrocaribbean, Amerindian and Mestizo communieties

The 1,753 plant records generated from the surveys of the nine communities included in the analysis covered 389 species from 300 genera and 98 families. Among the species total, 247 were used in the Amerindian communities, 148 in the Afrocaribbean communities and 107 in the Mestizo communities. The surveyed Amerindian communities used 78 plant families, the Afrocaribbeans used 64 and the Mestizos used 56. Four botanical families accounted for the highest number of species in all three groups: Fabaceae, Asteraceae, Lamiaceae and Euphorbiaceae. These families are well represented in the Caribbean flora and coincides with their high diversity worldwide [46]; indeed; the same results have been reported for the first three families in countries as varied as China, Peru, Ethiopia, Malaysia, Italy and Argentina [47-52]. Moerman [53] states that the high richness of species with medicinal applications in some plant families is determined by the chemical components they contain, and that specific families can be more effective in treating certain conditions. Other authors propose that the more common a family is in an area, the greater is the probability of its medicinal use [54]. Each group used different numbers of native and exotic species: Afrocaribbean (99 natives, 49 exotics); Amerindian (201 natives, 46 exotics); and Mestizo (63 natives, 44 exotics). The proportion of natives to exotics was significantly different in the Afrocaribbean (Z = 4.11, P < 0.01) and Amerindian (Z = 9.86, P < 0.01) communities, but not in the Mestizo communities (Z = 1.84, P > 0.01). There were significant differences in native and exotic plant use by groups (X = 21.95, P < 0.001). When compared between groups, significant differences in the proportion of natives to exotics were present between the Afrocaribbean and Amerindian communities (X = 10.63, P < 0.001), and between the Amerindian and Mestizo communities (X = 19.93, P < 0.001), but not between the Afrocaribbean and Mestizo communities (X = 1.72, P = 0.19). Therefore, native plant species represented a large portion of the medicinal plants used in the Amerindian (81%) and Afrocaribbean (67%) communities, and somewhat less in the Mestizo communities (59%). The high proportion of natives used by the Amerindians is both a result of millennia of cultural development in the region and a partial reflection of their preservation of indigenous knowledge in the face of historical events, i.e. a kind of cultural resistance. Hoffman [23] claims that indigenous groups that have lived in an area for long periods have a deeper knowledge of regional resources than non-indigenous groups that have lived there for less time. Incorporation of exotic plants into their Pharmacopoeia manifests the Amerindians’ flexibility in the adoption of new resources. This contributes to diversification of the medicinal species used by a group as an alternative health care option, which would agree with Albuquerque’s diversification hypothesis [55]. The overall Pharmacopoeia (natives and exotics plants) used by the Afrocaribbean and Mestizo groups is the result of the integration of mainly African, European and native components, and manifests the genetic and cultural mixture of regional historical processes. During approximately three hundred years, Africans arrived in the region as slaves. They brought their own therapeutic knowledge with them, but, due to the inherent restrictions of slavery, initially had access only to plant resources (mainly from Europe, Africa and Asia) directly introduced by Europeans as crops, ornamentals and medicinal [4,7,8,56]. Before indigenous populations were decimated in some areas, African immigrants were able to exchange knowledge about natural resource use with indigenous groups [57]. As Brussell observes [58], the rapid destruction of indigenous populations in some portions of the Basin did not necessarily lead to destruction of their natural resources and their knowledge of them. Afrocaribbean populations managed to incorporate a large number of native plant species into their therapeutic practices. They experimented with resources similar to those they had known in their points of origin, and very probably used organoleptic analysis and intuition, as has been the case in other human groups [6,59]. One example is the Camdomblé religious traditions of Salvador, Bahía, Brazil, which include both native and exotic Ficus species [60]. The less proportion of native plants used by the Mestizos is the result of a complex set of interactions between diverse factors mainly historical and cultural ones, since a short occupation of a territory limits the acquisition of extensive ethnobotanical knowledge which are orally transmitted. However, the influence of diverse cultures to which they have been exposed, have generated an open identity to accept resources from different sources, so a greater number of exotic species incorporated in their Pharmacopoeia is observed.

Main diseases treated with medicinal plants by Afrocaribbeans, Amerindians and Mestizos

Among the three analyzed groups, the largest number of medicinal plant species used were for infectious and parasite diseases; symptoms and signs; digestive system diseases; and respiratory system diseases (Table 3). The greater diversity of plants used to treat these disorders in these communities may be due to their frequency and the risk that they represent in public health terms. In a 2004 report, the WHO listed twelve diseases responsible for the largest number of deaths among women and men worldwide, which included infectious and parasite diseases; respiratory system infections; respiratory system diseases; and digestive system diseases [61,62]. The WHO also listed the twenty diseases with the highest death rates for all ages, ranking infectious respiratory diseases in third place (4.2 million deaths) and diarrheal diseases in fifth place (2.2 million deaths) [61].
Table 3

Number of medicinal species used in each category of disease for the three groups

Categories of disease Afrocaribeans Amerindians Mestizos
Number of species
Infectious and parasitic diseases (diarrhea, intestinal parasites, thrush)478323
Symptoms, signs and abnormal findings (headache, fever, itching)468232
Diseases of the digestive system (stomach cramps, flatulence, gastritis)418240
Diseases of the respiratory system (asthma, flu, cough)315348
Diseases of the genitourinary system (urinary infections, kidney stones, inflammation of ovaries)283928
Injury, poisoning and certain other consequences of external causes (wound, poisoning, scorpion stings, snake bite)24234
Diseases of the skin and subcutaneous tissue (boils, abscesses, sores).234912
Diseases of the circulatory system (hypertension, heart palpitations, circulatory problems)23419
Diseases of the musculoskeletal system (fractures, back pain, inflammation blow)21246
Diseases of the nervous system (attacks of nerves, hysteria, epilepsy)81114
Diseases of the ear and mastoid process (earache)4123
Endocrinal, nutritional and metabolic diseases (anemia, uric acid, diabetes)2122
Pregnancy, childbirth and the puerperium (birth complications, retained placenta, lack of milk).044
Diseases of the eye and adnexa (burning eyes, fleshy eye, eye irritation)051

Listed between brackets are 3 examples of ailments we recorded in each category.

Number of medicinal species used in each category of disease for the three groups Listed between brackets are 3 examples of ailments we recorded in each category.

Species use value in the three studied groups

Mean species UV values in each group did not differ (H = 2.09; 0.35 Kruskal-Wallis) with 0.88 ± 0.83 for the Afrocaribbean communities, 0.94 ± 1.01 for the Amerindian communities and 0.99 ± 0.81 for the Mestizo communities. The Afrocaribbean communities had 36% species with a use value greater than or equal to its mean use value, the Amerindian communities had 34% and the Mestizo communities had 42%. Among the Afrocaribbean communities, the highest use value (5.33) was for Momordica charantia L., used to treat skin and subcutaneous diseases; endocrine, nutritional and metabolic diseases; infectious and parasite diseases; symptoms and signs; cardiovascular system diseases; digestive system diseases; genital-urinary system diseases; and muscle-skeletal system diseases. For the Amerindian communities, the highest use value (7.33) was for Aloe vera (L.) Burm, used to treat skin and subcutaneous diseases; endocrine, nutritional and metabolic diseases; injuries, poisoning and other external consequences; cardiovascular system diseases; and digestive system diseases. Among the Mestizo communities, the highest use value (4.00) was for Plectranthus amboinicus (Lour.) Spreng, used in treatment of ear diseases; symptoms and signs; cardiovascular system diseases; digestive system diseases; nervous system diseases; and respiratory system diseases (Table 4).
Table 4

Species with use value ≥ mean species UV values in each group

Species and families Categories ICD-WHO Afro Ame Mes R Voucher number
Momordica charantia L. - Cucurbitaceae I, IV, VI, IX, X, XI, XII, XIII, XIV, XVIII, XIX5.331.333.33EGarcía 2329
Citrus aurantium L. - Rutaceae I, VI, X, XI, XIII, XVIII, XIX4.674.001.67EJiménez 1507
Citrus aurantiifolia (Chrisym.) Swimgle. Rutaceae I, IV, VI, IX, X, XI, XIV, XVIII, XIX3.336.671.67EJiménez 1499
Chromolaena odorata (L.) R.M. King & H. Rob. Asteraceae I, VI, X, XI, XII, XIV, XVIII, XIX,2.671.331.00NMedina 181
Aloe vera (L.) Burm. - Xanthorrhoeaceae I, IV, VI, IX, XI, XII, XIII, XIV, XVIII, XIX2.007.333.00EJiménez 1525
Petiveria alliacea L.- Phytolaccaceae X, XI, XII, XIII, XVIII1.672.331.33NJiménez 24
Annona muricata L. - Annonaceae I, VI, IX, X, XI, XVIII1.333.332.67NFORPLAN 1695
Psidium guajava L. - Myrtaceae I, X, XI, XII, XIII, XVIII, XIX1.333.331.67NJiménez 41
Persea americana Mill. - Lauraceae I, IV, X, XII, XIII, XIV, XVIII1.004.331.67NGirón 245
Chenopodium ambrosioides L. - Amaranthaceae I, IX, XI, XVIII1.002.331.67NJiménez 1511
Ricinus communis L.- Euphorbiaceae I, X, VIII, XI, XII, XIII, XIV, XVIII, XIX3.331.670EJiménez 47
Citrus sinensis (L.) Osbeck - Rutaceae I, X, XI, XIII, XVIII3.3300EVeloz 3010
Gossypium barbadense L. - Malvaceae I, VIII, XI, XII, XIII, XIV, XVIII, XIX3.0000EGarcía 2588
Saccharum officinarum L. - Poaceae I, VI, XI, XII, XIX3.0000EMejía 9024
Lantana camara L. - Verbenaceae X, XI, XVIII2.3300NGirón 197
Zea mays L. -Poaceae I, IX, XII, XIII, XIV, XVIII, XIX2.001.330NGirón 240
Musa paradisiaca L. - Musaceae I, XIII, XVIII2.0001.00EJiménez 691
Kalanchoe pinnata (Lam.) Pers. - Crassulaceae IX, X, XIII2.0000EOchoa 274
Haematoxylum campechianum L. - Fabaceae I, XIX, XVIII, XI2.0000NRouzier 104
Ocimum gratissimum L. - Lamiaceae I, XI2.0000EMejía 1399
Ocimum campechianum Mill. - Lamiaceae I, VIII, XI, XII, XVIII, XIX1.673.670NMedina 276
Allium sativum L. - Amaryllidaceae I, IX, X, XI, XII, XV1.673.330EJiménez 1519
Guazuma ulmifolia Lam. - Malvaceae I, IX, X, XIII1.6700NPimentel 1164
Zingiber officinale Roscoe - Zingiberaceae I, X, XI, XIII, XIV, XVIII1.332.330EOchoa 315
Carica papaya L. - Caricaceae I, VIII, IX, XI, XIII1.331.670NGirón 227
Mangifera indica L. - Anacardiaceae I, IX, XII, XIV1.3300EGirón 810
Spondias mombin L. - Anacardiaceae I, XII, XIII, XIV1.3300NMedina 84
Crescentia cujete L. - Bignoniaceae VI, XII, XIII, XIV1.3300NJiménez 22
Terminalia catappa L. - Combretaceae IX, XI1.3300EArvigo 1061
Cucurbita moschata Duchesne - Cucurbitaceae I, XIV, XVIII1.3300NJiménez 127
Abelmoschus esculentus (L.) Moench - Malvaceae I, XIV, XVIII, XIX1.3300EJiménez 683
Moringa oleífera Lam. - Moringaceae X, XI, XVIII1.3300ERouzier 129
Ocimum basilicum L. - Lamiaceae I,VI, VII, IX, X, XVIII1.003.670EGirón 168
Nicotiana tabacum L. - Solanaceae VIII, XII, XIX, XVIII, XIX1.001.670NGirón 130
Tournefortia hirsutissima L. - Boraginaceae X, XVIII1.001.670NVeloz 3024
Lippia graveolens Kunth - Verbenaceae VIII, XIV, X, XI, XVIII03.670NOcampo 88
Bursera simaruba (L.) Sarg. - Burseraceae I, XI, XII, XVIII, XIX03.331.00NAker 492
Hamelia patens Jacq. - Rubiaceae VII, VIII, XII, XVIII, XIX03.330NMedina 173
Ruta chalepensis L. - Rutaceae I, VI, VIII, X, XI, XIV, XVIII03.330EMedina 236
Parthenium hysterophorus L. - Asteraceae X, XII, XIII, XIV, XIX03.000NArvigo 1097
Cymbopogon citratus (DC.) Stapf - Poaceae IX, X, XI, XIV, XVIII02.671.33EGarcía 2654
Cecropia peltata L. - Urticaceae I, IV, X, XI, XIII, XIV02.671.00NMedina 215
Allium schoenoprasum L. - Amaryllidaceae I, VIII, X, XI02.670EMedina 125
Spondias purpurea L. - Anacardiaceae I, XI, XII, XVIII02.670NMedina 84
Cocos nucifera L. - Arecaceae I, XI, XII, XIV, XVIII02.331.33EJiménez 1512
Piper auritum Kunth - Piperaceae X, XI, XII, XIII, XV, XVIII02.331.33NGirón 273
Capraria biflora L. - Schrophulariaceae I, XII, XIV02.331.00NMedina 27
Artemisia ludoviciana Nutt. - Asteraceae I, X, XI02.330EMedina 53
Tagetes erecta L. - Asteraceae X, XI, XII, XIII, XVIII02.330NMedina 237
Bixa orellana L. - Bixaceae I, XI, XVIII02.330NMedina 267
Struthanthus orbicularis (Kunth) Blume Lorantaceae XI, XII, XIII, XIV02.330NMedina 224
Byrsonima crassifolia (L.) Kunth - Malpighiaceae I, XII, XVIII02.330NMedina 69
Eryngium foetidum L. - Apiaceae I, X, XI, XVIII02.000NJiménez 125
Kalanchoe integra (Medik.) Kuntze Crassulaceae I, X, XII, XVIII02.000EMedina 8
Plantago major L. - Plantaginaceae I, XI, XII, XIV, XVIII01.672.00EMedina 48
Heliotropium angiospermum Murray Boraginaceae I, X, XI, XIX01.670NMedina 152
Clinopodium ludens (Shinners) A Pool. Lamiaceae I, X, XI01.670NMedina 50
Brosimum alicastrum Sw. - Moraceae VI, X, XV, XIX01.670NParedes 254
Manilkara zapota (L.) P. Royen - Sapotaceae I, IV01.670NMedina 39
Plectranthus amboinicus (Lour.) Spreng. Lamiaceae VI, VIII, IX, X, XI, XVIII01.334.00EGarcía 7541
Annona squamosa L. - Annonaceae I, IX, X, XVIII01.332.00NMedina 55
Anacardium occidentale L. -Anacardiaceae I, X01.331.00NFLORPAN 1870
Rauvolfia tetraphylla L. -Apocynaceae I, VII, XII01.330NMéndez 2476
Aristolochia maxima Jacq. - Aristolochiaceae IV, XI, XIX01.330NMedina 171
Aristolochia odoratissima L.- Aristolochiaceae X, XVIII01.330NFLORPAN 5695
Ehretia tinifolia L. - Boraginaceae X, XV, XVIII01.330NMéndez 2448
Drymaria cordata (L.) Willd. ex Schult. Caryophyllaceae X, XI, XVIII01.330NJiménez 1353
Mentha citrata Ehrh - Lamiaceae I, XI01.330EMedina 287
Pilocarpus racemosus Vahl - Rutaceae XI, XIII, XVIII01.330NMedina 203
Urera baccifera (L.) Gaudich. ex Wedd. Urticaceae XIII, XVIII, XIX01.330NMedina 289
Mentha nemorosa Willd. - Lamiaceae I, IX, X, XI, XVIII002.67ERoig 4621
Justicia pectoralis Jacq. - Acanthaceae VI, IX, XI, XVIII002.33NMartinez 4758
Pluchea carolinensis (Jacq.) G. Don. Asteraceae VI, IX, XVIII002.33NMedina 159
Mentha piperita L. - Lamiaceae VI, IX, X, XI, XVIII002.33EMedina 54
Origanum majorana L. - Lamiaceae I, X, XI, XVIII002.33EBoucourt 4759
Ruta graveolens L.- Rutaceae VI, VIII, X, XI, XVIII002.33ESoberats 90-04
Bidens pilosa L. - Asteraceae X, XI, XII, XVIII002.00NBoucourt 4767
Ocimum sanctum L. - Lamiaceae I, IV, IX, X, XI, XVIII002.00EMejía 9143
Simarouba glauca DC. - Simaroubaceae VI, X, XVIII002.00NJiménez 40
Lippia alba (Mill.) N.E. Br. - Verbenaceae VI, VIII, XI, XVIII002.00NFLORPAN 1933
Turnera ulmifolia L. Passifloraceae I, VI, XI, XIV001.67NMéndez 149
Tradescantia spathacea Sw. - Commelinaceae X, XIII, XV001.33NJiménez 30
Rhizophora mangle L. -Rhizophoraceae XI, XII, XIV001.33NDurán 433

Categories ICD-WHO: I = Infectious and parasitic diseases; IV = Endocrinal, nutritional and metabolic diseases; VI = Diseases of the nervous system; VII = Diseases of the eye and adnexa; VIII = Diseases of the ear and mastoid process; IX = Diseases of the circulatory system; X = Diseases of the respiratory system; XI = Diseases of the digestive system; XII = Diseases of the skin and subcutaneous tissue; XIII = Diseases of the musculoskeletal system; XIV = Diseases of the genitourinary system; XV = Pregnancy, childbirth and the puerperium; XVIII = Symptoms, signs and abnormal findings; XIX = Injury, poisoning and certain other consequences of external causes.

Afro = Afrocaribbeans; Ame = Amerindians ; Mes: Mestizos; R = Natural range (N = Native plants; E = Exotic plants).

Species with use value ≥ mean species UV values in each group Categories ICD-WHO: I = Infectious and parasitic diseases; IV = Endocrinal, nutritional and metabolic diseases; VI = Diseases of the nervous system; VII = Diseases of the eye and adnexa; VIII = Diseases of the ear and mastoid process; IX = Diseases of the circulatory system; X = Diseases of the respiratory system; XI = Diseases of the digestive system; XII = Diseases of the skin and subcutaneous tissue; XIII = Diseases of the musculoskeletal system; XIV = Diseases of the genitourinary system; XV = Pregnancy, childbirth and the puerperium; XVIII = Symptoms, signs and abnormal findings; XIX = Injury, poisoning and certain other consequences of external causes. Afro = Afrocaribbeans; Ame = Amerindians ; Mes: Mestizos; R = Natural range (N = Native plants; E = Exotic plants). Some species had high use value (i.e. greater than or equal to the mean) in all three groups: Aloe vera; Citrus aurantiifolia (Chrisym.) Swimgle; Citrus aurantium L.; Chenopodium ambrosioides L.; and Psidium guajava L. In contrast, other high use value species were only such in one of the groups: Afrocaribbean, Gossypium barbadense L., Saccharum officinarum L., Haematoxylum campechianum L., Ocimum gratissimum L. and Spondias mombin L.; Amerindian, Lippia graveolens Kunth, Ruta chalepensis L., Punica granatum L., Byrsonima crassifolia (L.) Kunth, and Struthanthus orbicularis (Kunth) Blume; and Mestizo, Mentha nemorosa Willd., Origanum majorana L. Ruta graveolens L., Justicia pectoralis Jacq. and Bidens pilosa L. Although 60% of the high use value species in all three groups are natives, the two species with the highest use value in all three groups are exotics. This may result from the interviewees being almost all housewives with greater access to cultivated species in family gardens or crop systems. In addition, these species have other uses, such as food. Bennett and Prance [6] report similar findings in South America where use of exotics is common because medicinal value is assigned to plants used primarily as food; for example, Citrus aurantium, Citrus aurantifolia, Cocos nucifera and Allium cepa. Exotic species are normally cultivated and can be found in family gardens, making them easily available.

Similarity and differences in the use of medicinal plant species between groups

All communities compared in pairs showed similarity index values around 27%. The Afrocaribbean and Amerindian communities had 54 plant species in common, the Afrocaribbean and Mestizo communities had 35 in common and the Amerindian and Mestizo communities had 48 in common. This similarity may be due to migrations within the Caribbean Basin and consequent cultural intermixing. Segregation of the medicinal plant species repertoires used by the three groups can be explained by the different origin and respective cultural prevalence of each ethnic community, which would result in species exclusive to each group. Several studies state that human migration influences local medicinal knowledge as new remedies are introduced [63-65]. The present results demonstrate this enrichment of medicinal knowledge in that the Amerindian, Afrocaribbean and Mestizo groups clearly adapted their medicinal plant repertoires to incorporate both native and exotic species and also the medicinal plant diversity each group knows, since they only share 27% of species between groups. In the PCA analysis considering plant species use value in each group, the principal axis explained 57% of variation and clearly separated the Amerindian group from the Afrocaribbean and Mestizo groups (0.901 correlation) (Figure 1). Axis two explained 24% of variation and separated the Afrocaribbean group from the Amerindian and Mestizo groups (0.812 correlation). The Mestizo group exhibited very low correlation between the axes. This analysis reflects differences between the groups based on species use value. The point cluster near the union of the three vectors corresponds to species with similar values in two and even all three groups, whereas the points along the vectors are high use value species used exclusively by one of the groups (Figure 1).
Figure 1

Principle Component Analysis (PCA) with projection of the variables (Afrocaribbean, Amerindians and Mestizos) and the observations (use values of medicinal species) in the plane of axes 1 and 2.

Principle Component Analysis (PCA) with projection of the variables (Afrocaribbean, Amerindians and Mestizos) and the observations (use values of medicinal species) in the plane of axes 1 and 2. Eighty-three species were exclusive used by the Afrocaribbean group, of which 57 are native and 26 exotic; of these, high use value species include Saccharum officinarum (3.00), Gossypium barbadense (3.00), Haematoxylum campechianum (2.00), Ocimum gratissimum (2.00), Abelmoscus esculentus (L.) Moench (1.33), Spondias mombin L. (1.33), and Moringa oleifera Lam. (1.33), among others. Species with high use value in this group, but that were not exclusive to it include Momordica charantia (5.33), Ricinus communis L., (3.33) Citrus sinensis (L.) Osbeck (3.33), Chromolaena odorata (L.) R.M. King & H. Rob. (2.67), Lantana camara L. (2.33), and Annona muricata L. (2.33), among others. One hundred sixty-nine species were exclusive to the Amerindian group, of which 150 were natives and 19 exotic. Exclusive species with the highest UV included Lippia graveolens (3.67), Ruta chalepensis (3.33), Punica granatum (3.33), Artemisia ludoviciana Nutt. (2.33), Byrsonima crassifolia (2.33), Bixa orellana L. (2.33), Tagetes erecta L. (2.33), and Struthanthus orbicularis (Kunth) Blume (2.33), among others. High use value species shared with other groups included Aloe vera (7.33), Persea americana Mill. (4.33), Ocimum basilicum L. (3.67), Lippia graveolens (3.67), and Ocimum campechianum Mill. (3.67), among others. In the Mestizo group, 48 species were exclusive, 26 of which were native and 22 exotic. High use value exclusive species in this group included Mentha nemorosa (2.67), Origanum majorana L. (2.33), Ruta graveolens (2.33), Justicia pectoralis (2.33), Bidens pilosa (2.00), and Simaruba glauca D.C. (2.00), among others. Shared species with high use value included Plectranthus amboinicus (4.00), Mentha nemorosa (2.67), Pluchea carolinensis (Jacq.) G. Don (2.33) and Tamarindus indica L. (2.33), among others. Mixture of native and exotic species by immigrant groups is also a manifestation of their efforts to survive in new environments by mixing indigenous knowledge with their own knowledge. This is a kind of knowledge hybridization like that described by Coe and Anderson [30] among Afrocaribbean groups influenced by the Miskito, Suma and Rama indigenous groups in Nicaragua. Another example is the medicinal plant repertoire used on the island of Montserrat, of which only 15% is of Amerindian origin [66]. Medeiros and his collaborators [67] suggest five factors that affect incorporation of local pharmacopeia resources and knowledge, among them the prevailing health conditions in populations and the intensity of contact between immigrant and local populations. When considered in tandem with the floral richness of the Caribbean Basin derived from its biogeographic history, these two factors help to better understand the amalgam of plant species used for therapeutic purposes among the Basin’s populations. Even so, the influences of migration, cultural mixture and knowledge hybridization in the region have not blurred the clear differences between the studied groups’ repertoires of medicinal plants used for primary health care.

Conclusions

Although migration, cultural intermixing and a consequent hybridization of medicinal plant knowledge have occurred in the Caribbean Basin, the results highlight differences between the three studied groups in terms of the medicinal plant repertoire they employ for primary health care.
  21 in total

1.  Biodiversity hotspots for conservation priorities.

Authors:  N Myers; R A Mittermeier; C G Mittermeier; G A da Fonseca; J Kent
Journal:  Nature       Date:  2000-02-24       Impact factor: 49.962

2.  Creation of a clinical classification. International statistical classification of diseases and related health problems--10th revision, Australian modification (ICD-10-AM).

Authors:  K Innes; J Hooper; M Bramley; P DahDah
Journal:  Health Inf Manag       Date:  1997 Mar-May       Impact factor: 3.185

Review 3.  The medicinal flora of Native North America: an analysis.

Authors:  D E Moerman
Journal:  J Ethnopharmacol       Date:  1991-01       Impact factor: 4.360

4.  TRAMIL ethnopharmalogical survey in Les Saintes (Guadeloupe, French West Indies): a comparative study.

Authors:  Isabelle Boulogne; Lionel Germosén-Robineau; Harry Ozier-Lafontaine; Marie Fleury; Gladys Loranger-Merciris
Journal:  J Ethnopharmacol       Date:  2010-11-19       Impact factor: 4.360

5.  Traditional phytotherapy and trans-cultural pharmacy among Turkish migrants living in Cologne, Germany.

Authors:  Andrea Pieroni; Harald Muenz; Minire Akbulut; Kemal Hüsnü Can Başer; Cenk Durmuşkahya
Journal:  J Ethnopharmacol       Date:  2005-10-31       Impact factor: 4.360

6.  Mao's heritage: medicinal plant knowledge among the Bai in Shaxi, China, at a crossroads between distinct local and common widespread practice.

Authors:  Caroline S Weckerle; Robert Ineichen; Franz K Huber; Yongping Yang
Journal:  J Ethnopharmacol       Date:  2009-03-24       Impact factor: 4.360

Review 7.  Cross-cultural adaptation in urban ethnobotany: the Colombian folk pharmacopoeia in London.

Authors:  Melissa Ceuterick; Ina Vandebroek; Bren Torry; Andrea Pieroni
Journal:  J Ethnopharmacol       Date:  2008-09-18       Impact factor: 4.360

8.  [Traditional medicine in the Central Plateau of Haiti. 2. Ethnopharmacologic inventory].

Authors:  B Weniger; M Rouzier; R Daguilh; D Henrys; J H Henrys; R Anton
Journal:  J Ethnopharmacol       Date:  1986-07       Impact factor: 4.360

9.  Maya medicinal plants of San Jose Succotz, Belize.

Authors:  T Arnason; F Uck; J Lambert; R Hebda
Journal:  J Ethnopharmacol       Date:  1980-12       Impact factor: 4.360

10.  The use of medicinal plants by migrant people: adaptation, maintenance, and replacement.

Authors:  Patrícia Muniz de Medeiros; Gustavo Taboada Soldati; Nélson Leal Alencar; Ina Vandebroek; Andrea Pieroni; Natalia Hanazaki; Ulysses Paulino de Albuquerque
Journal:  Evid Based Complement Alternat Med       Date:  2011-11-10       Impact factor: 2.629

View more
  2 in total

1.  Medicinal plants cultivated in urban home gardens in Heredia, Costa Rica.

Authors:  Roxana González-Ball; Tania Bermúdez-Rojas; Marilyn Romero-Vargas; Melissa Ceuterick
Journal:  J Ethnobiol Ethnomed       Date:  2022-02-12       Impact factor: 2.733

2.  Phytotherapies in motion: French Guiana as a case study for cross-cultural ethnobotanical hybridization.

Authors:  M-A Tareau; A Bonnefond; M Palisse; G Odonne
Journal:  J Ethnobiol Ethnomed       Date:  2020-09-16       Impact factor: 2.733

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.